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Abstract The federal Housing Opportunities for Persons
with AIDS (HOPWA) program addresses housing needs of
low-income persons living with HIV/AIDS (PLWHA). The
New York City (NYC) Department of Health and Mental
Hygiene oversees 22 HOPWA contracts for over 2,400
clients, and manages the NYC HIV Registry. HOPWA
clients (N = 1,357) were matched to a random 20 %
sample of other PLWHA (N = 13,489). Groups were
compared on HIV care retention, viral suppression, and
rebound. HOPWA clients were, on average, 3 years
younger and more likely to be concurrently diagnosed with
HIV and AIDS. While HOPWA clients were more likely to
be retained in care (94 vs. 82 %; mOR = 2.97, 95 % CI
2.35–3.74), they were no more likely to achieve suppres-
sion (84 vs. 86 %; mOR = 0.85, 95 % 0.70–1.03) and
were more likely to rebound (11 vs. 7 %; mOR = 1.45;
95 % CI 1.10–1.91). HIV care retention does not fully
translate to virologic suppression in this low-income ser-
vice population.
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Introduction
Public funds are spent each year to address the needs of
homeless and unstably housed persons living with HIV/
AIDS (PLWHA). In fiscal year 2012, $332 million dollars
were granted nationally to Housing Opportunities for Per-
sons with AIDS, also known as HOPWA, a housing
assistance program that was established by the US
Department of Housing and Urban Development (HUD)
through the National Affordable Housing Act of 1990. The
New York City (NYC) Department of Health and Mental
Hygiene (DOHMH), the designated HOPWA grantee for
NYC, received $55 million dollars in fiscal year 2012 to
administer, manage, and reimburse the delivery of housing-
related supportive services [1]. In keeping with the goals of
the National HIV/AIDS Strategy (NHAS) and recent rec-
ommendations from the US Department of Health and
Human Services (DHHS), these HIV housing-related ser-
vices are aimed at increasing low-income individuals’
access to health care and essential resources for managing
illness, and thus reducing disparities in HIV health out-
comes [1–6].
The HIV care continuum, representing sequential stages
of care engagement from testing/diagnosis to successful
treatment/viral suppression, is a widely adopted framework
for measuring HIV health outcomes [7, 8]. ‘Near perfect’
adherence to antiretroviral treatment (ART) is required to
ensure success at the final stage of the continuum (viral
suppression), which is key both to individual health and
survival and to the prevention of onward HIV transmission
at the population level [9]. Homeless or unstably housed
PLWHA face particular barriers to achieving and main-
taining optimal HIV care outcomes, in that (1) they tend to
have lower CD4 cell counts and higher viral loads at
diagnosis (key biomarkers of HIV disease progression and
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predictors of mortality) [10]; (2) they have higher rates of
comorbid infections like hepatitis, tuberculosis, and
Pneumocystis carinii pneumonia than those who are stably
housed [11]; (3) they are less likely to adhere even with
access to ART because immediate subsistence needs like
food and shelter are not met [5, 12, 13]; and (4) providers
may not prescribe ART as readily to unstably housed
individuals, due to concerns that those patients will not be
adherent [14, 15]. Despite substantial federal and local
investments in HIV-related housing services and in pro-
moting HIV care and treatment engagement, few studies
have examined the effects of housing-related services on
outcomes along the HIV care continuum.
We aimed to assess HIV-related care outcomes among
PLWHA enrolled in the 22 NYC DOHMH-administered
HOPWA (hereafter ‘‘NYC HOPWA’’) programs in 2011,
and compare enrollees’ outcomes to those of a demograph-
ically and clinically similar group from the larger HIV-
infected population in NYC. We compared retention in care,
viral suppression (any and durable), and viral rebound
between NYC HOPWA clients and PLWHA not enrolled in
NYC HOPWA programs (‘‘other PLWHA’’), controlling for
group differences using propensity score matching. We
hypothesized that enrollment in NYC HOPWA programs
would be associated with better care outcomes.
Given the substantial public investment in HIV-related
housing programs, particularly in NYC and in the context
of strained resources for a growing HIV population [16],
there is a clear need for evidence of housing program
effectiveness. This analysis represents a first stage of
evaluation of the impact of the NYC HOPWA program
overall. This work will help to direct further analyses and
ultimately inform program refinements, priority-setting and
resource allocation in the broader domain of publicly
funded, HIV-related health and social services.
Methods
NYC HOPWA Program. The HOPWA program in NYC
offers three types of housing-related supportive services:
rental assistance (RA), housing placement assistance (HPA),
and supportive permanent housing (SPH) [2]. RA consists of
cash subsidies to establish or maintain permanent housing.
HPA consists of services that help individuals locate,
acquire, finance, and maintain permanent housing, but HPA
does not provide ongoing rental assistance. HPA can include
activities such as service plan development, escorts to
appointments, apartment inspections, advocacy, and coor-
dination of services to ensure that clients secure permanent
housing. SPH, the most comprehensive of the three, provides
affordable housing that is intended to be long-term [2, 17]. It
also provides comprehensive supportive services designed to
enhance management of HIV and other comorbid conditions
and improve self-sufficiency. Support services include but
are not limited to service plan development, advocacy,
escorts to appointments, health promotion and education,
mental health counseling, and substance use counseling [2,
12, 13, 17, 18]. To be eligible for NYC HOPWA services,
individuals must be HIV-infected and residing in NYC, with
a gross household income that does not exceed 50 % of the
median family income per HUD listings by family size for
NYC, and a documented need for housing financial assis-
tance [1–3]. Although levels of support vary by service type,
all NYC HOPWA clients are assigned to a case manager
responsible for at least quarterly assessment and reporting to
NYC DOHMH of clients’ engagement in HIV primary care.
Ethics Statement
The NYC DOHMH adheres to safeguards to ensure con-
fidentiality and privacy of individuals with HIV. Analysis
of HIV surveillance data is authorized for the purpose of
epidemiologic monitoring, as specified in the New York
Codes, Rules and Regulations, Title 10, Part 63 (Revised
2/12) [19].
Evaluation of HOPWA service programs is outside the
purview of institutional review boards (IRBs), provided
that access to identifying information is limited to staff
who help manage the HOPWA program under evaluation,
and that analyses are secondary, based on routinely col-
lected data for program management purposes [1]. For
these reasons, this analysis was exempt from human sub-
jects review requirements.
Data Sources
NYC HIV Surveillance Registry
The population-based NYC HIV Surveillance Registry
(‘the Registry’) is continuously updated with new labora-
tory results (i.e., CD4 counts and viral loads) and vital
status for all persons diagnosed with HIV infection or
AIDS, as defined by the Centers for Disease Control and
Prevention (CDC), and reported to the NYC DOHMH [20].
Name-based reporting of AIDS diagnoses was mandated
by New York State (NYS) law in 1983, followed by name-
based reporting of HIV in 2000 [19]. All data were drawn
from the Registry as of September 30, 2012.
NYC HOPWA Program Data
Starting in January 2008, the NYC DOHMH began receiving
named, client-level data from NYC HOPWA-funded agen-
cies, through a secure, web-based reporting system. Client-
level data collected for NYC HOPWA include full identifiers
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(such as first and last name), demographic characteristics,
enrollment information, type of services received and self-
reported data on clinical and HIV treatment histories.
HOPWA data included in this analysis were reported to the
NYC DOHMH as of February 2013.
Other NYC HIV Program Data
The NYC DOHMH also has access to named data from
additional HIV-related benefits and services programs
funded through the NYC DOHMH. Enrollment data from
these programs had already been merged into the Registry
dataset used for this analysis.
Merged Dataset
NYC HOPWA clients were matched to the Registry dataset
using a deterministic algorithm that incorporates first and last
name, date of birth, and social security number [21]. The
matched dataset included surveillance data such as age, race/
ethnicity, and concurrent diagnosis (i.e., an AIDS diagnosis
within 31 days of an HIV diagnosis), along with program-
matic data such as date of enrollment and type of services
received.
Eligibility Criteria
To be eligible for inclusion in the analysis as an NYC
HOPWA client, an individual had to: (1) be at least
18 years of age and diagnosed with HIV infection before
January 2011, (2) be reported to the NYC DOHMH by
September 2012, (3) receive NYC HIV medical care in
2010 (a proxy for residency in NYC), (4) be presumed
living as of the end of December 2011 (based on vital
statistics incorporated into the Registry), and (5) be
enrolled in NYC HOPWA as of January 1, 2011, in any
one of the three HOPWA service categories. Evidence of
medical care in 2010 was defined as having at least one
viral load (VL) or CD4 count laboratory test result reported
to the Registry in 2010. To be eligible for inclusion in the
analysis as a comparison group member, an individual had
to meet the same inclusion criteria detailed above, except
that they could not be enrolled in NYC HOPWA programs
at any time in 2010 or 2011. From this eligible subset of
PLWHA, a random sample of 20 % was selected to rep-
resent the final comparison group.
Analytic Variables
Outcome Variables
We used surveillance-based laboratory data on VL and
CD4 tests to assess engagement in HIV care and treatment
[22] during calendar year 2011. Results from these labo-
ratory data represent clinical health status, while dates of
test results represent the timing of care. Four outcomes
were constructed to describe engagement in care and
treatment: retention in care, viral suppression (two mea-
sures—any and durable), and viral rebound. Based on a
measure proposed in the NHAS, retention in care was
defined as C2 lab tests occurring C3 months apart over a
12-month period [4, 22, 23]. For the outcomes of viral
suppression and rebound, VL results were categorized as
either suppressed (B200 copies/mL) or unsuppressed
([200 copies/mL) [24]. Two measures of viral suppression
were constructed: (1) any suppression (having C1 sup-
pressed VL in the 12-month period, among those with at
least 1 VL); and (2) durable suppression (having C2 con-
secutive suppressed VLs at least 2 weeks apart in the
12-month period, among those with at least 2 VLs) [25,
26]. Following the DHHS standard, viral rebound was
defined as having an unsuppressed VL following two
consecutive suppressed VLs at least 2 weeks apart in the
12-month period, among those with at least 3 VLs [26, 27].
Exposure Variable
Enrollment in NYC HOPWA was the primary exposure
variable of interest, and was defined as being enrolled from
2010 into the start of calendar year 2011, the follow-up
observation period for outcome measures. Qualifying
enrollments could begin anytime between 2008 and 2010,
and span any number of days in 2011, as long as they
continued into 2011. We counted as NYC HOPWA
exposure a qualifying enrollment in any one (or more) of
the 22 NYC HOPWA programs. The NYC HOPWA
sample included enrollees (index clients) as well as any
HIV-infected adult dependents who may have directly or
indirectly received benefits (such as housing) from the
index client’s enrollment.
Covariates
For the construction of propensity scores estimating the
probability of NYC HOPWA exposure, we relied upon
nine variables that each significantly predicted HOPWA
enrollment and at least one outcome of interest (at the
alpha 0.05 level) in logistic regression models (data not
shown): HIV transmission risk category at diagnosis, age at
the end of 2011, race/ethnicity, sex, neighborhood-level
poverty (based on ZIP code at HIV or AIDS diagnosis),
country of origin, history of concurrent AIDS diagnosis,
last CD4 count as of December 31, 2010 (a proxy for
immunologic status), and enrollment in other local HIV
public assistance programs not administered by NYC
DOHMH. Concurrent diagnosis, a marker of delayed
AIDS Behav (2015) 19:2087–2096 2089
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testing, represents a missed opportunity for timely
engagement in care and treatment. Based on CDC’s clas-
sification system, HIV transmission risk was categorized as
injection drug use (IDU), sex between male partners
(MSM), heterosexual sex, or other/unknown.
Data Analysis
Propensity Score Matching
PLWHA who are enrolled in NYC HOPWA are expected
to systematically differ from other PLWHA on measured
and unmeasured baseline characteristics that relate to need
or eligibility for NYC HOPWA services. In randomized
controlled trials (RCTs), the groups would be assigned at
random to treatment conditions, so that analyses of treat-
ment effects would not be confounded by these differen-
tially distributed characteristics [28]. In observational
studies, propensity score matching functions to balance
baseline characteristics between two groups in order to
isolate and estimate the effect of treatment [29]. Groups of
subjects with the same score are presumed equally likely to
be in the treated and untreated groups. Matching by pro-
pensity score is then used to estimate the effect of treat-
ment status on the outcome of interest, ensuring that the
probability of receiving treatment is statistically similar
across groups [29].
In this analysis, NYC HOPWA clients were matched for
comparison to a random sample of other PLWHA. A 20 %
sample of the total eligible comparison group was selected
because of its minimal computational burden for the esti-
mation of propensity scores and its close approximation to
precision estimates when 100 % of non-HOPWA PLWHA
were included in an exploratory analysis (data not shown)
[30]. After calculating a propensity score for each person,
we performed optimal full matching, a method that allows
one or multiple treated subjects to be matched to one or
multiple untreated subjects [31]. Optimization attempts to
match sets of people such that any two propensity scores
within a set have the smallest possible ‘distance’ (the
smaller the distance, the more similar an exposed indi-
vidual is to the unexposed individual) [28]. The Optmatch
package in R (R Foundation, Vienna, Austria) was used to
construct matched sets of NYC HOPWA clients and other
PLWHA based on propensity scores [28]. We observed 620
matched sets, where more than half of the matched sets
(51 %) were between one exposed and one unexposed
person; the remaining sets consisted of multiple persons in
the exposed and/or unexposed groups. We evaluated the
extent to which optimal full matching balanced differences
between exposed and unexposed groups by examining
whether propensity score matching decreased the differ-
ence in percentages across covariates. If the difference
became less than 0.1, which was considered to be a neg-
ligible difference in a covariate between two groups on
average [32, 33], we concluded that the desired covariate
balance between two groups was achieved, and therefore
matching was effective (data not shown).
Summary Statistics and Logistic Regressions
To estimate the effect of NYC HOPWA enrollment (as of
the start of 2011) on retention, viral suppression (any and
durable), and viral rebound in 2011, we computed four
conditional logistic regression models accounting for the
matched sets. These models are referenced throughout as
‘matched analyses,’ and are represented in the resulting
matched odds ratios (mOR) and 95 % confidence intervals
(CI). For comparison, we also computed logistic regression
models of each of the four outcomes on NYC HOPWA
enrollment alone; these models, not conditioned on mat-
ched sets, are referenced throughout as ‘unmatched anal-
yses.’ Summary statistics on unmatched sets were
computed using Cochran–Mantel–Haenszel v2 tests for
general associations for categorical variables and inde-
pendent t tests for continuous variables, to assess soci-
odemographic differences by NYC HOPWA enrollment
status. SAS 9.2 software (SAS Institute Inc., Cary, NC) was
used to produce summary statistics and logistic regression
models.
Results
Of the 1,533 PLWHA enrolled in NYC HOPWA as of the
start of 2011, 1,357 (89 %) met the remaining eligibility
criteria and were matched to a 20 % random sample of
eligible other PLWHA reported to the Registry
(N = 13,489; Fig. 1). NYC HOPWA clients were, on
average, 3 years younger than other PLWHA (median age
in NYC HOPWA was 45 years), and more likely to be non-
Hispanic black (57 vs. 44 %), foreign-born (38 vs. 18 %),
previously incarcerated (18 vs. 12 %) and concurrently
diagnosed with HIV and AIDS (12 vs. 9 %). In both
groups, just under two-thirds had a history of an AIDS
diagnosis. NYC HOPWA clients were also more likely to
be enrolled in other local HIV public assistance programs
not administered by the NYC DOHMH (67 vs. 45 %) and
live in the highest poverty neighborhoods (32 % residing in
neighborhoods where 30–100 % of residents live below the
poverty line vs. 27 %). In addition, NYC HOPWA clients
were less likely to be male (59 vs. 70 %), report MSM
transmission risk (30 vs. 37 %), live in Manhattan at time
of diagnosis (19 vs. 27 %), or have higher CD4 counts at
the end of 2010 (44 % had CD4 counts C500 cells/mm3 vs.
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49 %). These differences were statistically significant at
the alpha 0.05 level (Table 1).
Regarding program exposure prior to the start of follow-
up, NYC HOPWA clients had been continuously enrolled
in NYC HOPWA for a median of 1.58 years from the start
of 2008 (the earliest point of electronic reporting of
HOPWA client-level information to the DOHMH) to the
start of 2011. Nearly half of HOPWA enrollees were
enrolled in SPH, one-third in HPA, and one-fifth in RA.
Clients enrolled in HPA had been enrolled for the least
amount of time, with a median duration of 0.33 years prior
to the start of follow-up (January 1, 2011), compared to RA
and SPH clients, who were enrolled for a median duration
of about 3 years prior to the start of follow-up (Table 1).
Regarding continued enrollment during the follow-up
period (calendar year 2011), the median number of days
enrolled was 365 for SPH, 365 for RA, and 151 for HPA.
Transition to other service provision programs during this
follow-up period was not tracked, though clients in any
NYC HOPWA program, and particularly those in the short-
term HPA program, may have transitioned from their initial
NYC HOPWA services program as of the start of 2011 to
other ongoing housing-related support services (adminis-
tered by NYC DOHMH or another agency).
NYC HOPWA clients were more likely to be retained in
care (94 vs. 82 %; see Table 2), with nearly three times the
odds of retention compared with other PLWHA in matched
analyses (mOR = 2.97, 95 % CI 2.35–3.74; Table 3).
Seventy-eight percent (78 %) of NYC HOPWA clients
experienced viral suppression, compared to 82 % of other
PLWHA (Table 2). The proportion of NYC HOPWA cli-
ents and other PLWHA achieving durable viral suppression
was similar (84 vs. 86 %; Table 2). While NYC HOPWA
clients appeared to have statistically significant decreased
odds of viral suppression (any or durable) in unmatched
analyses, associations did not persist in matched analyses
(mOR for any = 0.92, 95 % CI 0.72, 1.08 and mOR for
durable = 0.85, 95 % CI 0.70, 1.03; Table 3). However,
NYC HOPWA clients were more likely to experience viral
rebound (11 vs. 7 %; Table 2), and this association per-
sisted in both unmatched and matched analyses
(mOR = 1.45; 95 % CI 1.10, 1.91; Table 3).
Discussion
Compared to other PLWHA, NYC HOPWA clients had
significantly higher retention in care in 2011. The high
probability of being retained in HIV medical care is not
entirely surprising, since HOPWA clients are all actively
enrolled in HIV supportive services (and specifically ser-
vices that require routine assessment for HIV primary care
engagement) [1, 12, 34]. Both groups were substantially
higher on retention than the 45 % in 2009 estimated from
13 jurisdictions nation-wide [23].
The proportion of NYC HOPWA PLWHA who were
virally suppressed (among those with at least one VL test in
the year) is similar to the nationwide average of 77 % in
2010 [23, 35] and higher than the citywide average of 75 %
in 2011 [36]. Despite their greater retention in care, NYC
HOPWA clients were no more likely than other PLWHA to
achieve any or durable viral suppression. In both unmat-
ched and matched analyses, NYC HOPWA clients were
more likely than the other, similar NYC PLWHA to
NYC HOPWA clients who were enrolled as of 
January 1, 2011 
1,533 (100%)
Clients matched to the NYC HIV Surveillance 
Registry based on reporting through September 
30, 2012
1,431 (93%)
Presumed living at end of 2011
1,391 (97%)
At least 18 years of age at end of 2011
1,385 (99%)
No evidence of care in 
NYC in 2010
48 (2%)
Less than 18 years of age 
at end of 2011
6 (1%)
Some evidence of care in NYC in 2010
(at least 1 VL or CD4 test result)
1,357 (98%)
Not alive 
at end of 2011
40 (3%)
Not matched to a case in the 
NYC HIV Surveillance Registry 
as of September 30, 2012
102 (7%)
Fig. 1 Flow chart of NYC DOHMH-administered HOPWA program client eligibility for analysis
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Table 1 Selected characteristics of NYC DOHMH-administered HOPWA program clients and a random sample of other NYC PLWHA
NYC HOPWA clients Random sample of other PLWHA
N = 1,357 N = 13,489
N (%) N (%)
Risk
MSM 401 (30) 4,923 (37)
Heterosexuala 405 (30) 2,923 (22)
IDU 239 (18) 2,221 (16)
Other/Unknown 312 (23) 3,422 (25)
Age in years as of December 31, 2011
Mean 44.9 47.6
Median [IQR] 45 [38–52] 48 [41–55]
Sex
Male 795 (59) 9,508 (70)
Female 562 (41) 3,981 (30)
Race/ethnicityb
Non-Hispanic Black 773 (57) 5,949 (44)
Hispanic 520 (38) 4,476 (33)
Non-Hispanic White 50 (4) 2,756 (21)
Other 14 (1) 308 (2)
Borough of residence at diagnosisc
Bronx 259 (19) 2,644 (20)
Brooklyn 343 (25) 3,017 (22)
Manhattan 257 (19) 3,637 (27)
Queens 252 (19) 1,632 (12)
Staten Island 61 (4) 197 (1)
Outside of NYC 41 (3) 680 (5)
Unknown/Missing 144 (11) 1,682 (13)
Neighborhood-level povertyd
0 to\10 % 60 (4) 1,118 (8)
10 to\20 % 299 (22) 2,582 (19)
20 to\30 % 260 (19) 2,111 (16)
30 to 100 % 433 (32) 3,667 (27)
Missing 305 (23) 4,011 (30)
Country of origin
US 690 (51) 8,331 (62)
Foreigne 520 (38) 2,419 (18)
Unknown 147 (11) 2,739 (20)
History of incarcerationf
Yes 248 (18) 1,640 (12)
No 1,004 (74) 10,347 (77)
Missing 105 (8) 1,502 (11)
Enrolled in other HIV public assistance programs in 2011
Yes 907 (67) 6,094 (45)
No 450 (33) 7,395 (55)
Provider type at diagnosis
Outpatient facility 312 (23) 3,836 (28)
Inpatient facility 3,558 (26) 553 (41)
Screening/diagnostic/referral 52 (4) 389 (3)
Other 41 (3) 217 (2)
Missing 399 (29) 5,489 (41)
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experience the negative outcome of viral rebound, sug-
gesting a lesser ability to maintain optimal treatment out-
comes consistently over time.
This study is subject to a number of limitations. First,
the primary exposure of interest, as defined for this analysis
(enrollment as of January 2011 in NYC HOPWA), may not
suffice to capture the actual influence of these services on
multiple HIV-related medical outcomes. Enrollment does
not guarantee that services were actually received, nor does
it indicate a particular ‘dose’ of the treatment (i.e., number
and type of services, duration of services, prior HOPWA
services history, quality of services, level of participation,
etc.). Future analyses should determine whether there is a
threshold level (or dose) of NYC HOPWA services, or a
Table 1 continued
NYC HOPWA clients Random sample of other PLWHA
N = 1,357 N = 13,489
N (%) N (%)
Concurrent HIV/AIDS diagnosisg
Yes 160 (12) 1,202 (9)
No 1,197 (88) 12,287 (91)
AIDS as of December 31, 2011
N (%) 860 (63) 8,426 (62)
Median [IQR] year of diagnosis 2003 [1999–2007] 2002 [1997–2006]
Total number of unique test dates in 2011
N (%) 1,324 (98) 12,328 (91)
Mean [median, IQR] 3.4 [3.0, 3–4] 3.0 [3.0, 2–4]
Last CD4 count in 2010 (cells/mm3)
0–199 181 (13) 1,598 (12)
200–349 235 (17) 2,215 (16)
350–499 335 (25) 2,915 (22)
C500 601 (44) 6,587 (49)
Missing 5 (<1) 174 (1)
Duration of enrollment as of 12/31/2010, years (median [IQR]) 1.58 [0.4–3.0] N/A
Housing type
Housing placement assistance 415 (31) N/A
Rental assistance 366 (27)
Supportive permanent housing 576 (42)
Duration of enrollment by housing type, years (median [IQR])
Housing placement assistance 0.33 [0.1–0.7] N/A
Rental assistance 2.91 [1.3–3.0]
Supportive permanent housing 2.67 [1.3–3.0]
Numbers in bold denote statistical significance at the 0.05 level. Data as reported to the NYC DOHMH by September 30, 2012
PLWHA persons living with HIV/AIDS, HOPWA Housing Opportunities for Persons with AIDS, VL viral load, NYC New York City, MSM men
who have sex with men, IDU injection drug users, Med median, IQR interquartile range
a This transmission risk category includes heterosexual sex with an HIV-infected person, an injection drug user, or a person who has received
blood products. For females only, heterosexual risk also includes sex with a male and at least one of the following: history of commercial sex
work, multiple male sex partners, sexually transmitted infections, crack/cocaine use, sex with a bisexual male, probable heterosexual trans-
mission as noted in a medical chart, or negative history of injection drug use
b Due to small numbers, persons reporting more than one race, Native Americans or Alaskan Natives, Hawaiian Natives, Asians, and Pacific
Islanders were classified as ‘Other’ race/ethnicity
c Borough of residence refers to the residence at HIV diagnosis for persons living HIV (non-AIDS) or residence at AIDS diagnosis for persons
living with AIDS
d Neighborhood-level poverty, based on ZIP code at HIV or AIDS diagnosis, defined as percent of residents with incomes below 100 % of the
Federal Poverty Level per American Community Survey Census 2000
e Foreign refers to people known to have been born outside the US or US dependencies
f Data on history of incarceration are incomplete
g HIV cases concurrently diagnosed with AIDS (within 31 days of HIV diagnosis)
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specific type or pattern of NYC HOPWA service utilization
(RA, HPA and/or SPH), for which the evidence of program
effectiveness becomes clearer or more consistent.
Second, we may not have fully controlled for measured
variables in the construction of the propensity score. A
substantial proportion of NYC HOPWA enrollees and
PLWHA in the comparison group were concurrently
enrolled in other local HIV public assistance programs for
which DOHMH has client-level enrollment data. Thus,
both groups received other services that may reflect level of
need and could be expected to improve care outcomes.
Information on reason for or duration, dose, and type of
additional service exposures was not available, though, and
incomplete control of these factors may have affected the
construction of the propensity scores, introducing residual
confounding of the effect of NYC HOPWA program
enrollment. Also, residual confounding could have resulted
from not fully accounting for baseline clinical and immu-
nologic status, which was represented by a single indicator
(last CD4 count as of the end of 2010).
Third, we were not able to account for unmeasured
variables. Individual-level factors such as income, level of
educational attainment, employment status, mental health
status, hospitalizations, insurance status (i.e., private vs.
public) and substance use history are not systematically
and routinely reported to NYC DOHMH for surveillance
purposes, and therefore were not captured in this compar-
ison group analysis.
With regard to the inconsistent direction of findings on
health outcomes in this sample, NYC HOPWA clients may
Table 2 HIV-related care outcomes by NYC HOPWA status, 2011
NYC HOPWA clients Random sample of other PLWHA
N = 1,357 N = 13,489
N (%) N (%)
Retention in carea
Yes 1,296 (94) 11,127 (82)
No 88 (6) 2,362 (18)
Viral suppressionb
Yes 1,035 (78) 10,077 (82)
No 289 (22) 2,251 (18)
Durable viral suppressionc
Yes 818 (84) 7,688 (86)
No 174 (16) 1,292 (14)
Viral reboundd
Yes 92 (11) 495 (7)
No 735 (89) 6,135 (93)
Numbers in bold denote statistical significance at the 0.05 level. Data
as reported to the NYC DOHMH by September 30, 2012
NYC HOPWA New York City Housing Opportunities for Persons with
AIDS, PLWHA persons living with HIV/AIDS, VL viral load
a Retention in care defined as having C2 lab results C3 months apart
in 2011
b Viral suppression defined as having C1 VL B200 copies/mL in
2011, among those with at least 1 VL in 2011
c Durable suppression defined as having C2 consecutive VLs B200
copies/mL at least 2 weeks apart in 2011, among those with at least 2
VLs in 2011
d Viral rebound defined as having C1 VL[200 copies/mL after C2
VLs B200 copies/mL at least 2 weeks apart in 2011, among those
with at least 3 VLs in 2011
Table 3 Results of unmatched and matched logistic regressions of NYC HOPWA enrollment on measures of engagement in care, 2011
N Unmatched OR (95 % CI) Full optimal match ORa (95 % CI)
Retention in careb 14,468 3.06 (2.45, 3.81) 2.97 (2.35, 3.74)
Viral suppressionc 13,652 0.80 (0.70, 0.92) 0.92 (0.79, 1.08)
Durable viral suppressiond 9,972 0.79 (0.66, 0.94) 0.85 (0.70, 1.03)
Viral rebounde 7, 457 1.55 (1.23, 1.96) 1.45 (1.10, 1.91)
Numbers in bold denote statistical significance at the 0.05 level. Data as reported to the NYC DOHMH by September 30, 2012
NYC HOPWA New York City Housing Opportunities for Persons with AIDS, VL viral load, OR odds ratio, CI confidence interval
a Matched for race/ethnicity, age at the end of 2011, sex, neighborhood-level poverty, transmission risk, country of origin, concurrent diagnosis
(HIV & AIDS), enrollment in other local HIV public assistance programs in 2011, and last CD4 count as of the end of 2010. Neighborhood-level
poverty, based on ZIP code at HIV or AIDS diagnosis, represents the percent of residents living below the federally defined threshold for poverty,
and is categorized as: 0 to\10 %; 10 to\20 %; 20 to\30 %; and 30 to 100 %
b Retention in care defined as having C2 lab results C3 months apart in 2011
c Viral suppression defined as having C1 VL B200 copies/mL in 2011, among those with at least 1 VL in 2011
d Durable suppression defined as having C2 consecutive VLs B200 copies/mL at least 2 weeks apart in 2011, among those with at least 2 VLs in
2011
e Viral rebound defined as having C1 VL[200 copies/mL after C2 VLs B200 copies/mL at least 2 weeks apart in 2011, among those with at
least 3 VLs in 2011
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have higher retention in care for reasons related to their
assessed risk for suboptimal HIV outcomes. Perhaps NYC
HOPWA clients returned to care more often because pro-
viders scheduled them at more frequent intervals, based on
concerns about client health or compliance, or about losing
contact with the most transient clients. Such reasons for
higher visits frequency could explain the apparent contra-
diction of NYC HOPWA clients having more regular
interaction with medical care, but a roughly equal rate of
viral suppression and greater vulnerability to rebound [37–
39]. Sustained viral suppression also requires maintenance
of a daily behavior, all of the time, rather than a single
completed visit every several months. In this intent-to-treat
analysis, in which intervention exposure varied substan-
tially, differences in stability of housing and/or consistency
of health maintenance behaviors during the follow-up
period may partially explain inconclusive viral load results.
Further investigation is warranted to elucidate the rela-
tionship of NYC HOPWA, and specific NYC HOPWA
service types and doses, with HIV-related medical care
outcomes.
Despite these limitations, this analysis has several
strengths. It represents the first attempt to quantify
engagement in care and treatment of individuals receiv-
ing HIV housing services, in comparison to a similar
group in the larger HIV population. Additionally, NYC
offers an ideal setting in which to examine program
effectiveness, due to the large numbers of individuals
living with HIV and using HIV-related housing services
in the City, and due to named NYC HIV services
reporting to the DOHMH, as well as the mandatory
named HIV surveillance reporting in New York State
[19] yielding highly complete and linkable HIV-related
outcomes data [37]. However, despite vigorous efforts to
promote and evaluate housing stability as a means to
improve access to care as recommended by the NHAS
and DHHS [4, 7], optimal outcomes like durable viral
suppression without viral rebound remain elusive to
many PLWHA. Strengthening health care infrastructure
to deliver services that focus on basic needs as well as
HIV care and treatment remains critical to achieving an
AIDS-free generation [40, 41].
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